UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Whole-Genome Sequencing of a Healthy Aging Cohort

Cell, 2016-05, Vol.165 (4), p.1002-1011

2016

Volltextzugriff (PDF)

Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases

Genome medicine, 2019-12, Vol.11 (1), p.83-83, Article 83

2019

Volltextzugriff (PDF)

Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease

Science (American Association for the Advancement of Science), 2003-11, Vol.302 (5650), p.1578-1581

2003

Volltextzugriff (PDF)

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSOI)-IV substudy

Circulation (New York, N.Y.), 2003-07, Vol.108 (3), p.275-281

2003

Volltextzugriff (PDF)

Association between myeloperoxidase levels and risk of coronary artery disease

JAMA : the journal of the American Medical Association, 2001-11, Vol.286 (17), p.2136

2001

Volltextzugriff (PDF)

Evidence for the role of EPHX2 gene variants in anorexia nervosa

Molecular psychiatry, 2014-06, Vol.19 (6), p.724-732

2014

Volltextzugriff (PDF)

Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing

Clinical genetics, 2015-03, Vol.87 (3), p.225-232

2015

Volltextzugriff (PDF)

Patients with peripheral arterial disease in the CHARISMA trial

European heart journal, 2009-01, Vol.30 (2), p.192-201

2009

Volltextzugriff (PDF)

Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes

Journal of medical genetics, 2004-05, Vol.41 (5), p.334-341

2004

Volltextzugriff (PDF)

Frequency and long-term impact of myonecrosis after coronary stenting

European heart journal, 2002-06, Vol.23 (11), p.869-876

2002

Volltextzugriff (PDF)

Abciximab reduces mortality in diabetics following percutaneous coronary intervention

Journal of the American College of Cardiology, 2000-03, Vol.35 (4), p.922-928

2000

Volltextzugriff (PDF)

Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction : Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial

Circulation (New York, N.Y.), 1999-07, Vol.100 (1), p.14-20

1999

Volltextzugriff (PDF)

Perceptions of genetic counseling services in direct-to-consumer personal genomic testing

Clinical genetics, 2013-10, Vol.84 (4), p.335-339

2013

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Circulation (New York, N.Y.), 1999-11, Vol.100 (20), p.2045-2048

1999

Volltextzugriff (PDF)

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Circulation (New York, N.Y.), 1999-12, Vol.100 (25), p.2477-2484

1999

Volltextzugriff (PDF)

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

The American journal of cardiology, 2001-08, Vol.88 (3), p.230-235

2001

Volltextzugriff (PDF)

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

The American heart journal, 2001-12, Vol.142 (6), p.952-959

2001

Volltextzugriff (PDF)

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

Circulation (New York, N.Y.), 1996-10, Vol.94 (7), p.1528-1536

1996

Volltextzugriff (PDF)

Aspirin and clopidogrel resistance: an emerging clinical entity

European heart journal, 2006-03, Vol.27 (6), p.647-654

2006

Volltextzugriff (PDF)

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

The New England journal of medicine, 1996-09, Vol.335 (11), p.775-782

Topol, E J

1996

Volltextzugriff (PDF)

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials

British heart journal, 2003-10, Vol.89 (10), p.1200-1204

2003

Volltextzugriff (PDF)

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial

Circulation (New York, N.Y.), 2003-08, Vol.108 (8), p.921-924

2003

Volltextzugriff (PDF)

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization

The New England journal of medicine, 2001-06, Vol.344 (25), p.1888-1894

2001

Volltextzugriff (PDF)

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

Journal of the American College of Cardiology, 2005-09, Vol.46 (5), p.761-769

2005

Volltextzugriff (PDF)

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

The Lancet (British edition), 2001-06, Vol.357 (9272), p.1905-1914

VERHEUGT, Freek W. A

2001

Volltextzugriff (PDF)

1 – 25 von 593

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(581)
Mit Volltextzugriff
(529)

Publikationsform

Artikel
(593)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(580)
Female
(571)
Middle Aged
(500)
Science & Technology
(411)
Life Sciences & Biomedicine
(407)
Aged
(392)
Biological And Medical Sciences
(339)
Medical Sciences
(339)
Cardiovascular System & Cardiology
(302)
Cardiac & Cardiovascular Systems
(298)
Treatment Outcome
(199)
Cardiology. Vascular System
(157)
Myocardial Infarction - Drug Therapy
(151)
Angioplasty, Balloon, Coronary
(138)
Heart
(133)
Myocardial Infarction - Mortality
(133)
Risk Factors
(128)
Coronary Heart Disease
(119)
Follow-Up Studies
(117)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Whole-Genome Sequencing of a Healthy Aging Cohort

Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases

Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSOI)-IV substudy

Association between myeloperoxidase levels and risk of coronary artery disease

Evidence for the role of EPHX2 gene variants in anorexia nervosa

Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing

Patients with peripheral arterial disease in the CHARISMA trial

Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes

Frequency and long-term impact of myonecrosis after coronary stenting

Abciximab reduces mortality in diabetics following percutaneous coronary intervention

Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction : Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial

Perceptions of genetic counseling services in direct-to-consumer personal genomic testing

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

Aspirin and clopidogrel resistance: an emerging clinical entity

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

Aktive Filter

Suchergebnisse filtern